Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Total Debt
Short-term and long-term borrowings combined.
Microbot Medical Inc.NASDAQ: MBOT
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt rises 550.7% from a year ago
Total debt stood at $898K at the end of Q1 FY2026, up 550.7% from a year earlier and up 3.8% from the prior quarter. Over 3 fiscal years it compounded at +23.3% a year.
Context
- Total debt amounted to 1.2% of total assets at the end of Q1 FY2026, up 0.7 pp from a year earlier.
- Total debt increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total debt keeps rising in the next quarterly balance sheet after a +550.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 865K USD
- Year-over-year change
- +679.3%
- 4-year CAGR
- +6.2%
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 865K | +679.3% |
| FY2024 | 2024-12-31 | 111K | -51.9% |
| FY2023 | 2023-12-31 | 231K | -50.0% |
| FY2022 | 2022-12-31 | 462K | -32.1% |
| FY2021 | 2021-12-31 | 680K | — |
Total Debt vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +550.7% is the highest of 10, against a peer median of -3.5%.
- Total debt amounts to 1.2% of total assets for MBOT, versus a peer median of 3.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $28.51M USD | -53.2% | +13.6% | 13.6% | |
| Mar 2026 | $22.05M USD | +5.3% | -12.0% | 101.8% | |
| Mar 2026 | $18.28M USD | -3.5% | +170.3% | 43.1% | |
| Mar 2026 | $1.98M USD | -95.5% | +268.8% | 3.8% | |
| Mar 2026 | CA$1.92M CAD | +181.9% | +6.0% | 12.7% | |
| Mar 2026 | $1.46M USD | -89.9% | -6.7% | 0.6% | |
| Mar 2026 | $898K USD | +550.7% | +23.3% | 1.2% | |
| Mar 2026 | $761K USD | +152.8% | -2.6% | 0.3% | |
| Mar 2026 | $282.42K USD | +45.8% | +26.7% | 0.5% | |
| Mar 2026 | CA$116.71K CAD | -22.5% | +32.7% | 0.4% | |
| Peer median (excluding MBOT) | — | -3.5% | +13.6% | 3.8% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.